Interfering with leukocyte rolling ¿ a promising therapeutic approach in inflammatory skin disorders?
Michael P. Schön, Wolf-H. Boehncke
págs. 49-51
Characterization of the UDP-glucose receptor (re-named here the P2Y14 receptor) adds diversity to the P2Y receptor family
Maria P. Abbracchio, Eric A. Barnard, Jean-Marie Boeynaems
págs. 52-54
Using genome-wide mapping in the mouse to identify genes that influence drug response
James W. Watters, Howard McLeod
págs. 55-57
Crystallization of the human glucocorticoid receptor ligand binding domain: a step towards selective glucocorticoids
Brian M. Necela, John A. Cidlowski
págs. 58-60
Do unpredictable toxic side-effects of drugs reflect their promiscuous binding energies?
Alan Wiseman
págs. 61-62
Pharmacological effects of garlic extract
Ruomei Qi, Zhengang Wang
págs. 62-63
Empirical models and Hill coefficients
Jesús Giraldo
págs. 63-65
Too much of a good thing: adenosine overload in adenosine-deaminase-deficient mice
Michael R. Blackburn
págs. 66-70
Acquired somatic mutations in the molecular pathogenesis of COPD
Gary P. Anderson, Steven Bozinovski
págs. 71-76
Obesity ¿ a chronic health problem in cloned mice?
Akio Inui
págs. 77-80
Agonist induction and conformational selection during activation of a G-protein-coupled receptor
Patrick Vanderheyden, László Hunyady, Georges Vauquelin
págs. 81-86
Principles: Extending the utility of [35S]GTPS binding assays
Graeme Milligan
págs. 87-90
Endothelial nitric oxide synthase: the Cinderella of inflammation?
Giuseppe Cirino, Stefano Fiorucci, William C. Sessa
págs. 91-95
Cyclooxygenase 2: a molecular target for cancer prevention and treatment
Jaime Dannenberg, Kotha Subbaramaiah
págs. 96-102
© 2001-2026 Fundación Dialnet · Todos los derechos reservados
Coordinado por: